MFIM
TFFP

Mesirow Financial Investment Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Mesirow Financial Investment Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,601
Closed -$162K – 90
2022
Q3 		$162K Hold
1,601
– – 0.77% 68
2022
Q2 		$226K Sell
1,601
-4
-0.2% -$558 1.09% 59
2022
Q1 		$253K Buy
1,605
+5
+0.3% +$808 0.85% 70
2021
Q4 		$355K Hold
1,600
– – 1.02% 59
2021
Q3 		$309K Buy
1,600
+507
+46% +$108K 0.91% 70
2021
Q2 		$263K Buy
1,093
+4
+0.4% +$1.1K 0.67% 78
2021
Q1 		$369K Sell
1,089
-30
-3% -$12.2K 1% 62
2020
Q4 		$400K Sell
1,119
-277
-20% -$107K 1.27% 42
2020
Q3 		$645K Sell
1,396
-775
-36% -$219K 2.76% 1
2020
Q2 		$313K Sell
2,171
-59
-3% -$7.46K 1.47% 29
2020
Q1 		$214K Sell
2,230
-270
-11% -$32.1K 1.35% 50
2019
Q4 		$334K Buy
+2,500
New +$321K 1.41% 45

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mesirow Financial Investment Management's TFFP Position: Q4 2022 in Review

Mesirow Financial Investment Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2022, closing a stake of 1,601 shares — an estimated $162K sold.

Mesirow Financial Investment Management first reported a position in TFFP in Q4 2019 and held it in 12 quarters. The position peaked at $645K in Q3 2020. 41 funds tracked by Wall St. Rank hold TFFP as of Q4 2022.

  • Mesirow Financial Investment Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 1,601 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $162K.
  • Mesirow Financial Investment Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Mesirow Financial Investment Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $645K in Q3 2020.
  • 41 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2022, filed 19 Jan 2023.